Anna Richo joins Illumina's Board of Directors

Rhea-AI Summary

Illumina (NASDAQ: ILMN) announced the addition of Anna Richo to its Board of Directors, following shareholder approval at the annual meeting on May 16, 2024.

Richo brings over 30 years of global experience in legal, compliance, and regulatory roles, having served in senior positions at Cargill, UCB, Amgen, and Baxter Healthcare.

Illumina's CEO, Jacob Thaysen, highlighted Richo's expertise in biotechnology, biopharmaceutical, and medtech industries, which will aid in navigating the complexities of the company’s global operations.

Richo also holds director positions at Exelon, the Cargill Foundation, DePaul University, and Children's Minnesota Governance Board, and possesses degrees from Cornell University and DePaul University College of Law.

Positive

• Anna Richo has extensive experience in legal, compliance, and regulatory fields, enhancing Illumina’s governance.
• Richo’s background includes senior roles at Cargill, UCB, Amgen, and Baxter Healthcare, providing diverse industry insights.
• Her addition is expected to improve risk management and capture opportunities in global operations.
• Richo’s involvement with other boards and foundations adds valuable external perspectives to Illumina.

Negative

• The announcement does not directly address immediate business impacts such as revenue growth or cost management.
• Potential concerns about whether Richo’s multiple board responsibilities could limit her focus on Illumina.

Ms. Richo brings more than 30 years of global legal, compliance, and regulatory experience to Illumina's Board

SAN DIEGO, May 20, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that Anna Richo has joined the company's Board of Directors following shareholder approval of the director slate at the company's May 16, 2024, annual meeting. Ms. Richo currently serves as Corporate Senior Vice President, Strategic Advisor to the General Counsel and CEO at Cargill, Inc. a global food production and agricultural company.

Ms. Richo brings more than 30 years of regulated-industry experience as an attorney and legal executive, with extensive experience in compliance and business ethics, intellectual property, and corporate litigation. She formerly served as Corporate Senior Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary at Cargill, where she oversaw the company's corporate governance, global ethics and compliance, global security, global government relations, law, and shareholder relations functions.  

Prior to joining Cargill, Ms. Richo was Executive Vice President and General Counsel at UCB, a biopharmaceutical company based in Belgium. She also served as Senior Vice President and Chief Compliance Officer at Amgen, a global biotechnology company, and as Chief Litigation Counsel, Associate General Counsel, and Vice President of Law at Baxter Healthcare.

"I am thrilled to welcome Anna to our Board of Directors," said Jacob Thaysen, CEO of Illumina. "In today's evolving business and regulatory environment, her extensive global legal, compliance, and regulatory experience, including at biotechnology, biopharmaceutical, and medtech companies, will enhance our evaluation and understanding of the risks and opportunities associated with Illumina's expanding worldwide operations."

Ms. Richo also serves as a member of Exelon's Board of Directors, as a member of the Cargill Foundation Board of Directors, on the Board of Trustees for DePaul University, and on the Children's Minnesota Governance Board.

Ms. Richo holds a B.S. in Industrial and Labor Relations from Cornell University and a J.D. from DePaul University College of Law.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and connect with us on X(Twitter), Facebook, LinkedIn, Instagram, TikTok, and YouTube. 

Investors:
Salli Schwartz
858-291-6421
IR@illumina.com

Media:
Bonny Fowler
740-641-5579
PR@illumina.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/anna-richo-joins-illuminas-board-of-directors-302150329.html

SOURCE Illumina, Inc.

FAQ

What experience does Anna Richo bring to Illumina's Board of Directors?

Anna Richo has over 30 years of global legal, compliance, and regulatory experience, having held senior roles at Cargill, UCB, Amgen, and Baxter Healthcare.

When was Anna Richo approved to join Illumina's Board of Directors?

Anna Richo was approved to join Illumina's Board of Directors at the annual meeting on May 16, 2024.

What is Anna Richo’s current role at Cargill?

Anna Richo is the Corporate Senior Vice President and Strategic Advisor to the General Counsel and CEO at Cargill.

How will Anna Richo's expertise benefit Illumina?

Her expertise in legal, compliance, and regulatory areas will help Illumina navigate risks and opportunities in its global operations.

Which other boards does Anna Richo serve on?

Anna Richo also serves on the boards of Exelon, the Cargill Foundation, DePaul University, and the Children's Minnesota Governance Board.